CLINICAL_TRIALS trial_result · 2022-01-20

Clinical Trial Update: COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC [Phase 2]

Phase 2 pilot trial of COX-2 inhibition in LAM completed; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Brigham and Women's Hospital | Conditions: Lymphangioleiomyomatosis (LAM) | Phase 2 | Status: COMPLETED | Results posted: 2022-01-20